COMPANY PROFILE

Genome Medical

Explore full profile

Using telemedicine to integrate genomic medicine into everyday health care

San Francisco, United StatesFounded 2016Biotech & Life Sciences

Valuation $100–500M Latest valuation · 2021

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Genome Medical

Genome Medical is a startup operating in the healthcare sector, specifically in the field of genomic medicine. The company provides genetic counseling and services to patients through partnerships with healthcare organizations. Their primary aim is to make precision medicine more accessible to a larger number of patients.

Read full description

The company operates in the telehealth market, offering its services through a virtual care delivery model. This allows patients to access genetic counseling from the comfort of their homes, making it more convenient and accessible. Genome Medical's team of experts, including medical geneticists, genetic counselors, physicians, and pharmacists, provide personalized care based on each patient's unique genetic profile.

Genome Medical's business model revolves around providing genetic counseling before and after genetic testing. They help patients understand their genetic risk and the implications of various genetic testing options. This enables patients to make informed decisions about their health. The company partners with major genetic testing labs, giving healthcare organizations the flexibility to work with their preferred lab.

The company's revenue model is likely based on service fees charged to healthcare organizations and possibly to patients for their counseling services. They may also receive a commission from genetic testing labs for referrals.

In summary, Genome Medical is a telehealth startup that provides genetic counseling services to patients, helping them understand their genetic risks and make informed healthcare decisions. They operate in partnership with healthcare organizations and genetic testing labs, making precision medicine more accessible.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: San Francisco, United States
Employees: 75
Open positions: None listed
Dealroom signal: 63.3/100
Industry: Health
Sub-industry: BioTechnology, Health Platform
Sector: Biotech & Life Sciences, Biotechnology, DNA, Genetics and genomics, Telemedicine, Precision Medicine, Tech for Patients, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Investment activity: 1 company, latest Aug 2021
Capital deployed: —
Preferred round: ACQUISITION
Links: Website LinkedIn X

Latest news

Press, funding announcements and product moves mentioning Genome Medical.

See all news

Funding history

6 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES COther financing	Aug 2021	$60M	$240M	Flywheel Ventures · Canaan · Kaiser Permanente Ventures · Perceptive Advisors	—
SERIES BOther financing	Jul 2020	$14M	$56M	Kaiser Permanente Ventures · Illumina Ventures · Canaan · Samsung Catalyst Fund	—

Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

Genome Medical website traffic

Latest recorded traffic for Genome Medical is 39K monthly website visits, up 5.4% over the last three months. Genome Medical's team declined 8.5% over the past year.

Latest monthly visits39K 3-month web change+5.4% 1-year team growth-8.5%

Monthly website visitsOct 2017–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
GEGeneYouInGeneYouIn (GYI), a Canadian personalized medicine company, has developed a genome analytics and reporting platform called PillCheck	Toronto, Canada	Operational	12	$150K	—
GEGenooxA healthcare and technology company on a mission to make clinical genetic sequencing more accessible	Palo Alto, United States	Acquired
HEHelixThe leading population genomics company working at the intersection of clinical care, research, and genomics	San Mateo, United States	Operational
2323andMeHelping people access, understand, and benefit from the human genome	Sunnyvale, United States	Acquired
SMSkylit MedicalWe're developing a connected device to bring access to clear skin to over 40 million people in the US and 500 million worldwide who have psoriasis and eczema.	San Diego, United States	Operational
INInocrasProviding a comprehensive view of a patient's entire genetic profile through WGS analysis and interpretations	United States	Operational
NTNucleome TherapeuticsDecoding the dark matter of the human genome to discover first-in-class precision medicine	Oxford, United Kingdom	Operational
DLDante LabsDante Labs is transforming genetics	New York City, United States	Operational